Tirzepatide was recently approved by the US Food and Drug Administration, and may be more effective than GLP-1 agonists for weight loss
I made my own chart to create a visual representation of the treatment-group participant attrition Given this information, alternate names for this study might be: Only the people who arent regaining weight come back for the weigh-ins Only the people who are able to crash diet enough to make their weight look stable come back for the weigh-ins Most people dont make it 4 years on Semaglutide 2.4mg, which must be taken for life to even maybe perhaps have a chance, however small, of maintaining a small amount of weight loss Lets look at the next claim: Clinically meaningful weight loss occurred in both sexes and all races, body sizes and regions. Again, the population is massively skewed toward cis men and white people
In a phase 2 trial, VK2735 showed nearly 15% weight loss after 13 weeks, with up to 88% of participants achieving a weight loss of at least 10%
Its mechanism of action involves reducing appetite, increasing feelings of fullness, and slowing down the emptying of the stomach, ultimately resulting in lower calorie intake and weight loss
They handle short room-temperature periods during shipping, keep well in the fridge, and stay stable longest frozen at -20C or colder